RNA Sequencing Services Market Report 2026

RNA Sequencing Services Market Overview

• RNA Sequencing Services market size has reached to $3.99 billion in 2025 • Expected to grow to $6.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Personalized Medicine Drives RNA Sequencing Market Growth • Market Trend: Empowering Precision Medicine With Next-Generation Assays • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under RNA Sequencing Services Market?

RNA sequencing is a high-throughput technique used to analyze the presence and quantity of RNA molecules within a sample, providing insights into gene expression levels and transcriptomic dynamics. It is used to explore gene expression patterns and regulatory mechanisms in many biological processes, such as development, illness, and response to stimuli. The main types of RNA sequencing services are ribosomal RNA (rRNA), transfer RNA (tRNA), and long non-coding RNA (lncRNA). Ribosomal RNA (rRNA) sequencing refers to analyzing the RNA molecules that are components of ribosomes, essential for protein synthesis in cells. Various sequencing methods involve next-generation sequencing methods and others that are used in several application areas, such as research and diagnostic purposes. These services are used by various end users, including academic and government institutes and research centers, hospitals and clinics, pharmaceutical and biotechnology companies, and others.

What Is The RNA Sequencing Services Market Growth Forecast?

The rna sequencing services market size is expected to see strong growth in the next few years. It will grow to $6.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rising adoption of precision medicine approaches, increasing demand for transcriptomic data in diagnostics, expansion of pharmaceutical r&d activities, growing integration of ai-driven data analytics, increasing outsourcing of sequencing services. Major trends in the forecast period include increasing demand for high-throughput transcriptomic analysis, growing adoption of ngs-based rna sequencing, expansion of bioinformatics-integrated sequencing services, rising use of rna sequencing in clinical research, enhanced focus on data accuracy and reproducibility.

What Is The Driver Of The RNA Sequencing Services Market?

The growing demand for personalized medicine is significantly contributing to the growth of the RNA sequencing services market. Personalized medicine refers to tailoring medical treatment to individual characteristics, such as genetics or lifestyle, to optimize effectiveness and minimize adverse effects. The growing demand for personalized medicine is driven by its potential to provide more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. RNA sequencing services help to identify disease subtypes, discover biomarkers, identify therapeutic targets, predict therapy responses, and track disease progression and treatment results. Personalized medicine techniques use RNA sequencing technologies to give individualized and effective medicines that target the unique molecular characteristics of individual patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA (Food and Drug Administration) approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Thus, the increasing demand for personalized medicine is driving the growth of the RNA sequencing services industry going forward.

Key Players In The Global RNA Sequencing Services Market

Major companies operating in the rna sequencing services market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen NV, BGI Genomics Co Ltd, Azenta Inc., Novogene Co Ltd, Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, Genomax Technologies Pte Ltd, Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics, Novaseq Services Ltd

Global RNA Sequencing Services Market Trends and Insights

Major companies operating in the RNA sequencing services market are focusing on automation to reduce potential human error, such as the next-generation sequencing (NGS) assay, aiming to enhance efficiency and accuracy in data generation and analysis. The RNA next-generation sequencing (RNA-seq) assay is a powerful tool used in molecular biology and genomics to analyze the transcriptome of a biological sample. For instance, in June 2023, Tempus, a US-based precision medicine technology company, unveiled its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, designed for solid tumors, offers a comprehensive analysis of the entire transcriptome, highlighting clinically significant fusions in over 100 targeted genes, along with altered splicing for MET Exon 14 and EGFRvIII. Recognizing the significance of RNA sequencing data, Tempus has historically incorporated both RNA and DNA sequencing into its standard xT broad-panel assay. Now, clients have the flexibility to order each test separately or simultaneously, with the option to supplement xR with certain Tempus algorithmic tests. This offering caters to physicians with a specific interest in RNA fusions or altered splicing, as well as providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis of their existing samples.

What Are Latest Mergers And Acquisitions In The RNA Sequencing Services Market?

In January 2024, Parse Biosciences, a US-based life sciences company, acquired Biomage Ltd. for an undisclosed amount. With this acquisition, Parse Biosciences aims to enhance its single-cell RNA sequencing data analysis capabilities, providing customers with improved tools for deeper insights and reduced analysis time in genomic research and precision medicine applications. Biomage Ltd. is a UK-based company offering RNA sequencing data analysis, enhanced genomic research, and precision medicine applications.

What Defines the RNA Sequencing Services Market?

The RNA sequencing services market includes revenues earned by offering sequencing services for RNA analysis, encompassing sample preparation, sequencing, data analysis, and interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the RNA Sequencing Services Market Report 2026?

The rna sequencing services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rna sequencing services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.